How should I evaluate and manage a 45-year-old man presenting with a dry cough?

Evaluation and Management of Dry Cough in a 45-Year-Old Man

Immediate Red-Flag Assessment

First, actively screen for red-flag features that mandate urgent investigation before proceeding with routine evaluation. Ask specifically about hemoptysis, unintentional weight loss, fever, night sweats, significant dyspnea at rest or at night, hoarseness, and recurrent pneumonia—any of these requires immediate chest imaging and specialist referral to exclude malignancy, tuberculosis, or serious infection. 1, 2, 3 In a 45-year-old with new-onset cough, particularly if he smokes, lung cancer screening criteria may be met and urgent evaluation is essential. 1

Duration Classification

Establish the exact duration of cough in weeks, as this single datum fundamentally determines your diagnostic pathway. 1, 3

• Acute cough (<3 weeks): Almost always viral and self-limiting; no specific therapy needed beyond symptomatic relief with honey-lemon mixtures. 2 Chest radiograph is only indicated if red flags are present. 2

• Subacute cough (3–8 weeks): Most commonly post-infectious (≈48% of cases), but also consider asthma exacerbation (≈16%), upper airway cough syndrome (≈33%), or non-asthmatic eosinophilic bronchitis (≈5%). 1

• Chronic cough (>8 weeks): Requires systematic investigation starting with mandatory chest radiograph and spirometry. 1, 4

Medication and Smoking Review

Immediately review all medications and discontinue any ACE inhibitor, as this is a common and easily reversible cause of dry cough. 1, 2, 3 ACE inhibitor-induced cough typically resolves within a median of 26 days (up to 40 weeks) after cessation. 1

Document smoking status in detail. If he is a current smoker, prioritize smoking cessation as the primary intervention—smoking-related cough improves within 4 weeks after quitting in most cases. 1, 3 A 45-year-old smoker with new-onset cough raises concern for both COPD and lung cancer. 1

Mandatory Baseline Investigations for Chronic Cough

Obtain a chest radiograph and spirometry with bronchodilator testing for any cough lasting >8 weeks. 1, 4 These are non-negotiable baseline investigations to exclude infectious, inflammatory, or malignant thoracic disease and to detect obstructive airway pathology. 1

Quantify cough severity using visual analog scales or validated quality-of-life questionnaires to objectively monitor treatment response. 1

Systematic Evaluation for the "Big Four" Etiologies

In a non-smoker with normal or near-normal chest radiograph, four conditions account for >90% of chronic dry cough cases: upper airway cough syndrome (UACS), asthma, gastroesophageal reflux disease (GERD), and non-asthmatic eosinophilic bronchitis (NAEB). 1, 4, 5

Upper Airway Cough Syndrome (UACS)

• UACS is the single most frequent cause, accounting for 18.6–81.8% of chronic cough cases. 1
• UACS may present without prominent nasal symptoms such as post-nasal drip, making recognition challenging. 1
• Ask about frequent throat clearing, nasal congestion, or chronic rhinitis. 3
• When upper-airway symptoms are present, initiate a trial of topical nasal corticosteroids for 1 month. 1, 2

Asthma (Including Cough-Variant Asthma)

• Asthma accounts for 14.6–41.3% of chronic cough and may present as cough alone without wheeze or dyspnea. 1, 6, 4
• Normal spirometry does NOT exclude asthma-related cough. 1, 5 No pulmonary function test can reliably exclude a cough that would respond to corticosteroids. 1
• If spirometry is normal and asthma is suspected, perform methacholine bronchial provocation testing after referral to a pulmonologist. 1, 5 A positive test confirms cough-variant asthma in ≈88% of cases. 1
• Initiate inhaled corticosteroids according to national asthma guidelines. 1
• A 2-week trial of oral prednisone (30–40 mg daily) helps differentiate eosinophilic airway inflammation; lack of improvement suggests the cough is unlikely due to asthma. 1, 2

Gastroesophageal Reflux Disease (GERD)

• GERD is implicated in 4.6–85.4% of chronic cough and frequently occurs without any gastrointestinal symptoms. 1, 4, 5
• Failure to consider GERD is a frequent cause of therapeutic failure. 1
• Initiate intensive acid suppression with a proton-pump inhibitor (omeprazole 20–40 mg twice daily before meals) plus alginates for a minimum of 3 months. 1, 2 Clinical response may require 2–12 weeks. 1
• Add dietary and lifestyle modifications, including removal of medications that may aggravate reflux (bisphosphonates, nitrates, calcium-channel blockers, theophylline). 1

Non-Asthmatic Eosinophilic Bronchitis (NAEB)

• NAEB contributes to 6.4–17.2% of chronic cough cases and is characterized by eosinophilic airway inflammation without airway hyperresponsiveness or variable airflow obstruction. 1, 5
• Inhaled corticosteroids are effective in reducing cough severity in NAEB. 1

Empiric Treatment Algorithm

Because up to 67% of patients have multiple simultaneous etiologies, retain partially effective therapies and employ additive treatment strategies rather than sequential monotherapy. 1, 4

1. First step: If upper-airway symptoms are present, start topical nasal corticosteroids. 1
2. Second step: If UACS treatment fails or spirometry/methacholine challenge suggests asthma, initiate inhaled corticosteroids or a 2-week trial of oral prednisone. 1, 2
3. Third step: If cough persists after addressing upper-airway and asthma causes, begin intensive acid suppression for GERD for ≥3 months. 1, 2

Symptomatic Relief for Acute or Severe Dry Cough

For severe dry cough interfering with sleep or quality of life, recommend honey combined with lemon as first-line non-pharmacological therapy. 2 Patients experience relief comparable to over-the-counter preparations without cost or adverse effects. 2

If pharmacological therapy is needed, prescribe dextromethorphan 30–60 mg for short-term use (≤7 days). 2 The standard OTC dose of 15–30 mg is subtherapeutic for severe dry cough. 2 Maximum cough-reflex inhibition occurs at 60 mg; do not exceed 120 mg daily. 2 Avoid codeine-containing products—they offer no advantage over dextromethorphan and have a significantly higher adverse-effect profile (drowsiness, nausea, constipation, risk of dependence). 2, 7

Inhaled menthol provides acute, short-duration cough-reflex suppression useful for immediate symptom relief. 2

Advanced Investigation When Empiric Therapy Fails

If all empiric treatments fail after 8 weeks, obtain high-resolution computed tomography (HRCT) of the chest to evaluate for bronchiectasis, interstitial lung disease, or occult masses. 1

Consider bronchoscopy when HRCT and prior work-up are inconclusive to assess for endobronchial lesions, sarcoidosis, eosinophilic bronchitis, or occult infection. 1

Refer to a specialist cough clinic when the condition remains undiagnosed after systematic evaluation of UACS, asthma, GERD, and NAEB. 1

Follow-Up and Outcome Measurement

Schedule a follow-up visit within 4–6 weeks to reassess cough severity using validated scales and to verify treatment adherence before abandoning a therapeutic trial. 1, 4

Discontinue antitussive therapy if cough persists beyond 3 weeks and pursue diagnostic work-up rather than continuing symptomatic treatment. 2

Common Pitfalls to Avoid

• Do not assume a single etiology—up to 67% of chronic cough patients have multiple concurrent causes requiring combination therapy. 1
• Do not rely on normal spirometry to exclude asthma—cough-variant asthma often presents with normal baseline pulmonary function tests. 1, 5
• Do not prescribe subtherapeutic dextromethorphan doses (15–30 mg) for severe dry cough. 2
• Do not neglect GERD as a cause even when gastrointestinal symptoms are absent. 1, 5
• Do not prescribe antibiotics for acute viral cough—most cases are self-limiting and antibiotics contribute to resistance without benefit. 2